Below you will find a link to a valuable new review article on ongoing changes in the opportunities for evaluation and management of men with both hormone-sensitive and castration-resistant, metastatic prostate cancer (mHSPC and mCRPC). This new article by Aggarwal et al. (“Emerging categories of disease in advanced prostate cancer and their therapeutic implications“) is […]![]()
